
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
TrialScope has acquired Clinical Trial Connect. As part of the acquisition, founder Mike Wenger will become part of the TrialScope team.
To learn more, click






